ArticleBiomedicines2024

Hepatic Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor Levels Decline in Hepatitis C but Are Not Associated with Progression of Hepatocellular Carcinoma.

Florian Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.